FA
WST icon

Fiducient Advisors’s West Pharmaceutical WST Stock Holding History

Fiducient Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,094
Closed -$964K – 170
2022
Q4 		$964K Buy
+4,094
New +$970K 0.28% 48

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fiducient Advisors's WST Position: Q1 2023 in Review

Fiducient Advisors sold out of West Pharmaceutical (WST) in Q1 2023, closing a stake of 4,094 shares — an estimated $964K sold.

Fiducient Advisors first reported a position in WST in Q4 2022 and held it in 1 quarter. The position peaked at $964K in Q4 2022. 695 funds tracked by Wall St. Rank hold WST as of Q1 2023.

  • Fiducient Advisors reported no remaining West Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Fiducient Advisors sold 4,094 West Pharmaceutical shares in Q1 2023, an estimated $964K.
  • Fiducient Advisors first reported a position in West Pharmaceutical in Q4 2022 and held it in 1 quarter.
  • Fiducient Advisors's West Pharmaceutical position peaked at $964K in Q4 2022.
  • 695 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Fiducient Advisors's 13F filing for Q1 2023, filed 8 May 2023.